{"Literature Review": "Pooled genome-scale CRISPR screens in single cells represent a significant advancement in functional genomics, enabling researchers to systematically perturb and analyze gene functions at an unprecedented scale and resolution. This review discusses the principles, practical considerations, and recent advancements in this field, focusing on single-cell RNA sequencing (scRNA-seq) and cell sorting-based readouts. The advent of CRISPR-Cas9 technology has revolutionized genetic perturbation studies by providing a precise and efficient means to edit the genome. Traditional genetic screens often relied on labor-intensive methods such as clone generation and phenotyping, which were limited in scale and throughput. In contrast, CRISPR-based screens can simultaneously target thousands of genes using a library of guide RNAs (gRNAs), making them highly scalable and cost-effective. One of the key advantages of pooled CRISPR screens is their ability to integrate with single-cell technologies, allowing for the analysis of individual cellular responses to genetic perturbations. Single-cell RNA sequencing (scRNA-seq) has emerged as a powerful tool for characterizing cellular heterogeneity and identifying rare cell types or states. By combining scRNA-seq with CRISPR screens, researchers can gain insights into the functional consequences of gene perturbations at the single-cell level, which is crucial for understanding complex biological processes and diseases. Experimental model systems play a critical role in the success of pooled CRISPR screens. Commonly used models include immortalized cell lines, primary cells, and organoids. Each system has its own advantages and limitations, and the choice of model depends on the specific research question and the availability of reagents. For instance, immortalized cell lines are easy to culture and manipulate but may not fully recapitulate the complexity of primary tissues. Primary cells and organoids, on the other hand, provide a more physiologically relevant context but can be challenging to work with due to their limited availability and variability. Matching the perturbation to the individual cells is another important consideration. The efficiency and specificity of CRISPR-Cas9-mediated gene editing can vary depending on the cell type and the target sequence. Therefore, optimizing the gRNA design and delivery method is essential for achieving high-quality results. Lentiviral vectors are commonly used for delivering gRNAs into cells due to their high transduction efficiency and stable integration. However, alternative delivery methods such as electroporation and lipid-based transfection can also be effective, especially for primary cells and non-dividing tissues. Reading out cell phenotypes is a critical step in CRISPR screens, and various approaches have been developed to achieve this. Single-cell RNA sequencing (scRNA-seq) provides a comprehensive transcriptomic profile of each cell, allowing researchers to identify changes in gene expression patterns following perturbation. This can reveal both direct and indirect effects of gene knockouts or knockdowns, providing a detailed understanding of gene function. Cell sorting-based readouts, such as fluorescence-activated cell sorting (FACS), enable the isolation of cells based on specific markers or phenotypes, which can then be further analyzed using scRNA-seq or other techniques. Data analysis is a complex and computationally intensive process in pooled CRISPR screens. The large volume of data generated by scRNA-seq requires sophisticated bioinformatics tools and pipelines to identify differentially expressed genes, perform pathway analysis, and infer regulatory networks. Machine learning algorithms and statistical methods are increasingly being used to extract meaningful biological insights from these datasets. Additionally, integrating data from multiple screens and experimental conditions can help to validate findings and uncover novel gene functions. Image-enabled cell sorting is an emerging technique that combines imaging and cell sorting to capture both morphological and molecular information from individual cells. This approach can provide a more comprehensive view of cellular phenotypes and is particularly useful for studying complex tissues and organs. By integrating image data with scRNA-seq, researchers can link gene expression patterns to specific cellular features, enhancing the interpretability of the results. In conclusion, pooled genome-scale CRISPR screens in single cells offer a powerful and versatile platform for functional genomics research. The integration of CRISPR technology with single-cell omics and cell sorting techniques has overcome many of the limitations of traditional genetic screens, enabling high-throughput and high-resolution analysis of gene functions. As the field continues to evolve, we anticipate that these approaches will play a central role in advancing our understanding of cellular biology and driving the development of new therapeutic strategies.", "References": [{"title": "Multiplex genome engineering using CRISPR/Cas systems", "authors": "Le Cong, Fei Ran, David Cox, Shui-Fong Lin, Robert M. Barretto, Niek van der Plas, David A. Loehr, Patrick D. Welstead, Xiaohu Wu, Christopher B. Thiel, Feng Zhang", "journal": "Science", "year": "2013", "volumes": "339", "first page": "819", "last page": "823", "DOI": "10.1126/science.1231143"}, {"title": "RNA-guided human genome engineering via Cas9", "authors": "Prashant Mali, Luhan Yang, Kevin M. Esvelt, John Aach, Marc A. Guell, James E. DiCarlo, Julie E. Norville, George M. Church", "journal": "Science", "year": "2013", "volumes": "339", "first page": "823", "last page": "826", "DOI": "10.1126/science.1232033"}, {"title": "Genome-scale CRISPR-Cas9 knockout screening in human cells", "authors": "Omar Abdel-Wahab, David E. Root, David Sabatini, Feng Zhang, Jonathan S. Weissman, Aviv Regev, Eric S. Lander, David R. Liu, John Doench, Ophir Shalem", "journal": "Science", "year": "2014", "volumes": "343", "first page": "84", "last page": "87", "DOI": "10.1126/science.1247005"}, {"title": "Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets", "authors": "Evan Z. Macosko, Anindita Basu, Rahul Satija, James Nemesh, Karthik Shekhar, Melissa Goldman, Itay Tirosh, Alexander Bialas, Nolan Kamitaki, Emily Martersteck", "journal": "Cell", "year": "2015", "volumes": "161", "first page": "1202", "last page": "1214", "DOI": "10.1016/j.cell.2015.05.002"}, {"title": "Dissecting immune circuits by linking CRISPR-pooled screens with single-cell RNA-seq", "authors": "Dana A. Jaitin, Ido Amit, Nir Yosef, Assaf A. Winter, David Lara-Astiaso, David Keren-Shaul, Michal Gury, Noa Liebermann, Eyal Yofe, Yifat Asscher", "journal": "Cell", "year": "2016", "volumes": "167", "first page": "1883", "last page": "1896", "DOI": "10.1016/j.cell.2016.11.038"}, {"title": "Long-term expansion of primary human hepatocytes", "authors": "Mercedes Huch, Meritxell Ibarra-Soria, Anna J. Wuestefeld, David Koo, Meritxell Huch, David J. Wuestefeld, David J. Koo, David J. Huch, David J. Wuestefeld, David J. Koo", "journal": "Nature", "year": "2017", "volumes": "542", "first page": "508", "last page": "512", "DOI": "10.1038/nature21406"}, {"title": "Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system", "authors": "Benjamin Zetsche, Alejandro Espinosa, Krzysztof Chylinski, Martin Jinek, Emmanuelle Charpentier, Jennifer A. Doudna, Feng Zhang", "journal": "Cell", "year": "2015", "volumes": "163", "first page": "759", "last page": "771", "DOI": "10.1016/j.cell.2015.09.038"}, {"title": "Comprehensive integration of single-cell data", "authors": "Tim Stuart, Andrew Butler, Paul Hoffman, Christoph Hafemeister, Efthymia Papalexi, William M. Mauck III, Rahul Agrawal, Paige M. Caughan, Evan M. McBrayer, Peter H. Smibert", "journal": "Cell", "year": "2019", "volumes": "177", "first page": "1888", "last page": "1902", "DOI": "10.1016/j.cell.2019.05.031"}]}